Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,611 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00756847 | Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors | completed | Phase 1 | 52 | SanofiINDUSTRY | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01057342 | Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 17 | Swiss Cancer InstituteOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00460668 | The Effect of Post-thoracotomy Pulmonary Rehabilitation on Quality of Life | completed | N/A | 57 | IsalaOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00556647 | Fast-track Diagnosis for Lung Cancer Suspects With PET-CT and EUS | completed | — | 297 | IsalaOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00517790 | Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 140 | AbbVie (prior sponsor, Abbott)INDUSTRY | 5 | Apr 5, 2013 | clinicaltrials |
| NCT00416650 | Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 16 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT01158495 | Outcome Measures in Infant/Early Childhood Lung Disease w/ Chest CT Scanning & Lung Function Testing | completed | — | 30 | Stanford UniversityOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT01392144 | Phase II Evaluation of Exhaled Nitric Oxide (NO) | completed | — | 36 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00002823 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 3 | 3,300 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 29 | Mar 28, 2013 | clinicaltrials |
| NCT00864110 | Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 4 | Cell>Point LLCINDUSTRY | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00865319 | Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 22 | Cell>Point LLCINDUSTRY | 2 | Mar 22, 2013 | clinicaltrials |
| NCT00560573 | Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 | 46 | PfizerINDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
| NCT00951613 | A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer | completed | Phase 2 | 72 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Mar 20, 2013 | clinicaltrials |
| NCT01814163 | Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab(ANGIOMET) | completed | — | 200 | Spanish Lung Cancer GroupOTHER | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00483639 | Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer | completed | — | 100 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT00284154 | Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer | completed | Phase 2 | 51 | SCRI Development Innovations, LLCOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00049998 | Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer | completed | Phase 3 | 760 | GlaxoSmithKlineINDUSTRY | 31 | Mar 4, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00028028 | CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00029003 | Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00075751 | Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 99 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00087412 | S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00777309 | A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 167 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 6 | Feb 28, 2013 | clinicaltrials |
| NCT00020709 | Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | completed | Phase 3 | 840 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00021060 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 842 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00077350 | A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00824746 | Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)(ReGaiN) | completed | Phase 2 | 23 | Chonnam National University HospitalOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01139619 | A Retrospective Study to Investigate the Current Situation of Biopsy Testing in Swedish Inoperable Non Small Cell Lung Cancer (NSCLC) Patients(MAPSY) | completed | — | 136 | AstraZenecaINDUSTRY | 1 | Feb 25, 2013 | clinicaltrials |
| NCT00004604 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | Duke UniversityOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00003884 | Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone | completed | Phase 3 | 600 | NovartisINDUSTRY | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00686465 | Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study(PETREC) | completed | N/A | 101 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00004137 | S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 88 | SWOG Cancer Research NetworkNETWORK | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00026156 | S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 125 | SWOG Cancer Research NetworkNETWORK | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00030433 | S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 85 | SWOG Cancer Research NetworkNETWORK | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00550173 | A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer | completed | Phase 2 | 247 | Eli Lilly and CompanyINDUSTRY | 7 | Feb 13, 2013 | clinicaltrials |
| NCT00075426 | Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 30 | The University of Texas Medical Branch, GalvestonOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00457119 | Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients | completed | Phase 1 | 69 | Novartis PharmaceuticalsINDUSTRY | 3 | Feb 12, 2013 | clinicaltrials |
| NCT01184534 | Multimedia Patient Education | completed | — | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00002537 | Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00002625 | Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 5 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004126 | Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 38 | University of ChicagoOTHER | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00005032 | Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 12 | University of ChicagoOTHER | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00005849 | Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | 15 | University of ChicagoOTHER | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00009971 | Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00025389 | Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | completed | Phase 2 | 8 | University of ChicagoOTHER | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00265317 | A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone(SUN1058) | completed | Phase 2 | 162 | PfizerINDUSTRY | 8 | Feb 6, 2013 | clinicaltrials |
| NCT00014066 | Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00280787 | Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim | completed | Phase 2 | 24 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00004201 | Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 0 | Feb 4, 2013 | clinicaltrials |
| NCT00500513 | Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials | completed | N/A | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 1, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 10, 2013source: clinicaltrials